The Enterprise Value as of November 2024 (TTM) for BIOLASE, Inc. (BIOL) is 10.10M

According to BIOLASE, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.10M. This represents a change of -22.14% compared to the average of 12.98M of the last 4 quarters.

BIOLASE, Inc. (BIOL) Historical Enterprise Value (quarterly & annually)

How has BIOL Enterprise Value performed in the past?

The mean historical Enterprise Value of BIOLASE, Inc. over the last ten years is 36.09M. The current 10.10M Enterprise Value has changed 2.70% with respect to the historical average. Over the past ten years (40 quarters), BIOL's Enterprise Value was at its highest in in the June 2021 quarter at 2.62B. The Enterprise Value was at its lowest in in the September 2023 quarter at 9.49M.

BIOLASE, Inc. (BIOL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BIOLASE, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BIOLASE, Inc. (BIOL) Average Enterprise Value

How has BIOL Enterprise Value performed in the past?

The current Enterprise Value of BIOLASE, Inc. (BIOL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BIOLASE, Inc. (BIOL) Enterprise Value vs. Peers

How is BIOL’s Enterprise Value compared to its peers?

BIOLASE, Inc.’s Enterprise Value is greater than Bone Biologics Corporation (-487010.00), greater than Bluejay Diagnostics, Inc. (-3621459.00), greater than Talis Biomedical Corporation (-37986434.00), greater than Nuwellis, Inc. (3.99M), greater than Heart Test Laboratories, Inc. (-887822.00), greater than Tivic Health Systems, Inc. (-143144.00), greater than NanoVibronix, Inc. (1.47M), less than Vivos Therapeutics, Inc. (10.80M), less than Bioventus Inc. (1.11B), less than Asensus Surgical, Inc. (107.57M), less than DexCom, Inc. (30.42B), less than Tandem Diabetes Care, Inc. (2.45B), less than Pacific Biosciences of California, Inc. (1.34B), less than Nano-X Imaging Ltd. (341.68M),

Build a custom stock screener for BIOLASE, Inc. (BIOL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BIOLASE, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BIOLASE, Inc. (BIOL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BIOLASE, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.